Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

diaDexus, Inc. Reports 2010 Third Quarter Financial Results

November 15, 2010 By Bio-Medicine.Org

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2010
/PRNewswire-FirstCall/ — diaDexus, Inc. (OTC Bulletin Board:
DDXS
), a diagnostics company focused on the development and
commercialization of patent-protected in vitro diagnostic
products addressing unmet needs in cardiovascular disease, today
announced financial results for the third quarter of 2010. Total
revenues for the 2010 third quarter at $3.2 million represented a
26% growth over total revenues of $2.5 million for the third
quarter of 2009. Net cash used in operating activities for the
third quarter of 2010 was $2.2 million.

Year-to-date revenues for the period ended September 30, 2010
were $8.5 million vs. $8.8 million in the same period a year ago, a
decrease primarily attributable to lower product sales due to a
related party’s reduced clinical trials testing. Revenues were also
impacted by the previously disclosed voluntary withdrawal of the
PLAC TIA Test in May 2010, one of the two formats of the PLAC Test.
Cash and short term investments at September 30, 2010 were $23.2
million compared to $4.8 million at December 31, 2009. The increase
is primarily a result of the reverse merger transaction with
VaxGen, Inc. completed July 28, 2010, from which diaDexus obtained
$23.4 million in cash and equivalents held by VaxGen, partially
offset by the repayment of debt and cash used in operating
activities.

Commenting on the financial results, Chief Executive Officer
Patrick Plewman stated, “We are pleased to report good growth
despite the lower related party sales and the voluntary withdrawal
of the PLAC TIA product. We believe we have addressed the root
cause of the PLAC TIA product performance issue, and a new 510(k)
for an enhanced PLAC TIA product was submitted to the FDA on June
30, 2010.” Mr. Plewman also commented, “The PLAC test provides
valuable information, over and above traditional risk factors, such
as

‘/>”/>

SOURCE

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Biotronik
FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech